“● YEOTOP6.COM ● ●꼴릴때●별내동오피✻별내동건마Ⅱ별내동출장ね별내동키스방❜별내동오피∇별내동스파☠별내동안마”的搜索结果，显示 381-390 项，共有 10220 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study of Nivolumab and Multi-fraction ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also, to improve disease control by decreasing the number of spinal relapses for ...

3. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   2. Olmsted County residents at the time of study entry. Exclusion criteria: 1. Pediatric population (age<18). 2. Unwilling to participate or unable to consent.

4. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 part to further assess the effectiveness and safety of JCAR017 monotherapy treatment at the recommended dose. A separate Phase 1 cohort will assess the ...

6. 神经科- 临床试验- 妙佑医疗国际

   A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma.

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and evaluate it to ...

8. 神经科- 临床试验- 妙佑医疗国际

   Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization ...

9. 神经科- 临床试验- 妙佑医疗国际

   This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

10. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...